FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

39476911000001105: Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Apr 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
618061000001113 Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
618071000001115 Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets Is a Co-careldopa 12.5mg/50mg tablets 90 tablet true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets Has AMP Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets Has specific active ingredient Carbidopa monohydrate true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-careldopa 12.5mg/50mg tablets (Bristol Laboratories Ltd) 90 tablet 9 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start